Clinical Trial Update: Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vitamin D supplementation as a neoadjuvant to photodynamic therapy for actinic keratoses has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Photodynamic Therapy
• Vitamin D supplementation (Cholecalciferol)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2022-06-24